| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 16, 2025 | HARROW, INC. | CEO | Sell | 37.5 | -79,994 | -2.61% | ✗ | $3.8M |
| Jul 21, 2025 | Jul 23, 2025 | HARROW, INC. | CEO | Sell | 15.0 | -313,338 | -9.79% | ✗ | $11.6M |
| Apr 3, 2025 | Apr 7, 2025 | HARROW, INC. | CEO | Sell | 16.3 | -300,363 | -10.36% | ✗ | $6.9M |
| Mar 22, 2024 | Mar 25, 2024 | HARROW, INC. | CEO | Buy | 65.0 | +9,000 | 0.42% | ✗ | $104.3K |
| Nov 16, 2023 | Nov 16, 2023 | HARROW, INC. | CEO | Buy | 65.0 | +7,500 | 0.37% | ✗ | $60.8K |
| Aug 14, 2023 | Aug 15, 2023 | HARROW, INC. | CEO | Buy | 65.0 | +5,800 | 0.29% | ✗ | $98.9K |
| Jul 18, 2023 | Jul 20, 2023 | HARROW, INC. | CEO | Sell | 16.3 | -299,968 | -12.99% | ✗ | $5.5M |
| Apr 3, 2023 | Apr 4, 2023 | HARROW, INC. | CEO | Sell | 37.5 | -117,633 | -7.07% | ✗ | $2.5M |
| Jan 2, 2023 | Jan 3, 2023 | HARROW, INC. | CEO | Sell | 20.0 | -35,179 | -2.31% | ✗ | $519.2K |
| Dec 22, 2022 | Dec 23, 2022 | HARROW, INC. | CEO | Buy | 85.0 | +25,000 | 1.78% | ✗ | $334.8K |
| Jan 20, 2022 | Jan 21, 2022 | HARROW, INC. | CEO | Sell | 20.0 | -71,406 | -4.83% | ✗ | $594.8K |
| Apr 25, 2021 | Apr 27, 2021 | HARROW, INC. | CEO | Sell | 17.5 | -334,129 | -19.80% | ✗ | $2.8M |
| Nov 15, 2018 | Nov 15, 2018 | Eton Pharmaceuticals, Inc. | Director | Buy | 82.5 | +10,000 | 1.27% | ✗ | $60K |
| Mar 3, 2017 | Mar 6, 2017 | Ideal Power Inc. | Director | Buy | 91.3 | +7,800 | 30.12% | ✗ | $19.8K |
| Dec 19, 2016 | Dec 21, 2016 | HARROW, INC. | CEO | Buy | 95.0 | +72,291 | 10.39% | ✗ | $135.3K |
| Nov 13, 2015 | Nov 17, 2015 | Ideal Power Inc. | Director | Sell | 22.5 | -29,063 | -34.59% | ✗ | $219K |
| Nov 27, 2013 | Dec 2, 2013 | Ideal Power Inc. | Director | Buy | 95.0 | +29,063 | 55.43% | ✗ | $101.1K |
| Feb 28, 2012 | Mar 15, 2013 | HARROW, INC. | CEO | Buy | 40.0 | - | 0.00% | ✗ | $147.2B |